- Home
- CAC vs HUMA Comparison
CAC vs HUMA Comparison
Compare CAC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAC
- HUMA
- Stock Information
- Founded
- CAC 1875
- HUMA 2004
- Country
- CAC United States
- HUMA United States
- Employees
- CAC N/A
- HUMA N/A
- Industry
- CAC Major Banks
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- CAC Finance
- HUMA Health Care
- Exchange
- CAC Nasdaq
- HUMA Nasdaq
- Market Cap
- CAC 680.5M
- HUMA 324.0M
- IPO Year
- CAC 1997
- HUMA N/A
- Fundamental
- Price
- CAC $38.81
- HUMA $1.69
- Analyst Decision
- CAC Buy
- HUMA Strong Buy
- Analyst Count
- CAC 3
- HUMA 7
- Target Price
- CAC $47.33
- HUMA $10.00
- AVG Volume (30 Days)
- CAC 83.8K
- HUMA 7.7M
- Earning Date
- CAC 10-28-2025
- HUMA 11-07-2025
- Dividend Yield
- CAC 4.33%
- HUMA N/A
- EPS Growth
- CAC 9.12
- HUMA N/A
- EPS
- CAC 3.49
- HUMA N/A
- Revenue
- CAC $215,172,000.00
- HUMA $818,000.00
- Revenue This Year
- CAC $42.11
- HUMA N/A
- Revenue Next Year
- CAC $5.51
- HUMA $1,468.13
- P/E Ratio
- CAC $11.11
- HUMA N/A
- Revenue Growth
- CAC 27.50
- HUMA N/A
- 52 Week Low
- CAC $34.53
- HUMA $1.15
- 52 Week High
- CAC $50.07
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- CAC 55.27
- HUMA 48.22
- Support Level
- CAC $37.01
- HUMA $1.65
- Resistance Level
- CAC $37.44
- HUMA $1.90
- Average True Range (ATR)
- CAC 1.19
- HUMA 0.11
- MACD
- CAC 0.24
- HUMA -0.01
- Stochastic Oscillator
- CAC 80.72
- HUMA 40.58
About CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.